Liberty Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$394K	Hold	5,040	–	–	0.08%	125
2025 Q1	$365K	Hold	5,040	–	–	0.08%	123
2024 Q4	$373K	Hold	5,040	–	–	0.08%	121
2024 Q3	$333K	Hold	5,040	–	–	0.07%	124
2024 Q2	$466K	Hold	5,040	–	–	0.11%	113
2024 Q1	$482K	Hold	5,040	–	–	0.12%	113
2023 Q4	$384K	Hold	5,040	–	–	0.1%	114
2023 Q3	$349K	Hold	5,040	–	–	0.1%	114
2023 Q2	$475K	Hold	5,040	–	–	0.14%	102
2023 Q1	$417K	Hold	5,040	–	–	0.14%	101
2022 Q4	$376K	Hold	5,040	–	–	0.13%	106
2022 Q3	$416K	Hold	5,040	–	–	0.16%	98
2022 Q2	$479K	Hold	5,040	–	–	0.17%	94
2022 Q1	$593K	Hold	5,040	–	–	0.17%	94
2021 Q4	$653K	Hold	5,040	–	–	0.18%	92
2021 Q3	$571K	Hold	5,040	–	–	0.17%	91
2021 Q2	$522K	Hold	5,040	–	–	0.16%	93
2021 Q1	$422K	Hold	5,040	–	–	0.15%	97
2020 Q4	$460K	Buy	+5,040	New	+$460K	0.17%	94
2020 Q2	$348K	Hold	5,040	–	–	0.15%	96
2020 Q1	$317K	Hold	5,040	–	–	0.17%	92
2019 Q4	$392K	Hold	5,040	–	–	0.16%	96
2019 Q3	$369K	Hold	5,040	–	–	0.16%	98
2019 Q2	$310K	Hold	5,040	–	–	0.14%	109
2019 Q1	$321K	Hold	5,040	–	–	0.16%	94
2018 Q4	$257K	Hold	5,040	–	–	0.16%	94
2018 Q3	$292K	Hold	5,040	–	–	0.15%	92
2018 Q2	$245K	Hold	5,040	–	–	0.14%	98
2018 Q1	$234K	Hold	5,040	–	–	0.14%	98
2017 Q4	$203K	Hold	5,040	–	–	0.11%	113
2017 Q3	$190K	Hold	5,040	–	–	0.1%	123
2017 Q2	$198K	Hold	5,040	–	–	0.12%	110
2017 Q1	$158K	Hold	5,040	–	–	0.1%	120
2016 Q4	$161K	Sell	5,040 -2,400	-32%	-$76.7K	0.1%	111
2016 Q3	$296K	Hold	7,440	–	–	0.19%	92
2016 Q2	$247K	Buy	+7,440	New	+$247K	0.17%	98